Hysterectomy - A Regional Intervention Study (HYSTERI)
Primary Purpose
Benign Hysterectomy, Postoperative Recovery, Preoperative Planning
Status
Recruiting
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Intiensified structured perioperative information
Sponsored by

About this trial
This is an interventional treatment trial for Benign Hysterectomy
Eligibility Criteria
Inclusion Criteria:
- Women 18 - 55 years old.
- Women undergoing hysterectomy for benign indication.
- Women with ASA 1 - 3.
- Women who understand and can express themselves in Swedish.
- Women who, by signing "Informed Consent", agree to participate in the study after written and oral information.
- Women who participate and respond to the surveys in the GynOp register.
- Women who have access to an I-phone, smartphone, computer or tablet and who can use the study-specific mobile application. (Does not apply to sub-study 1).
Exclusion criteria
- Women where both ovaries are removed during the operation.
- Women undergoing hysterectomy for prolapse indication.
- Women undergoing hysterectomy for cancer prophylactic indication.
- Women undergoing hysterectomy for gender reassignment purposes.
- Women with intellectual disabilities to such an extent that they can not fill in the relevant questionnaires etc. or if they do not understand the meaning of participating in the study or where there may be ethical doubts about the patient's participation in the study.
- Women who have a mental illness of such severity that the doctor in charge considers it inappropriate for the patient to be included in the study.
Sites / Locations
- University HospitalRecruiting
- VrinnevisjukhusetRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Intensified preoperative information
Control group
Arm Description
The patient participating in the intervention group is evaluated preoperatively based on an algorithm. This information is designed according to a checklist which includes how the procedure is performed, rules of conduct in connection with and after the procedure and what the patient can expect after surgery.
The patient who participates in the control group receives information about participation in the study as a control, ie without information about the intervention. The patient will then be planned for the procedure according to current, local routines.
Outcomes
Primary Outcome Measures
Unexpected postoperative symtoms
Proportion of patients with unexpected symptoms.
Proportion minimally invasive hysterectomy
Proportion of women undergoing hysterectomy as a minimally invasive procedure
Secondary Outcome Measures
Complication
Numbers of and types of patient reported complications
Lenght of stay
Hospital length of stay in connection with surgery
Sick leave
return to work measured as actual sick leave length
Recovery
time to normal daily activity (ADL)
Health related quality of life
Measured with EuroQol EQ-5D-3L health index comprising of two parts. Part A Scale -0.5941 to 1. A higher number indicates better quality of life. Part B. EuroQol visual analoque scale EQ-VAS. Scale 0-100. A higher number indicates better quality of life
Full Information
NCT ID
NCT05255120
First Posted
February 4, 2022
Last Updated
February 24, 2022
Sponsor
University Hospital, Linkoeping
1. Study Identification
Unique Protocol Identification Number
NCT05255120
Brief Title
Hysterectomy - A Regional Intervention Study
Acronym
HYSTERI
Official Title
The Effect of Systematic Preoperative Preparation on the Outcome of Benign Hysterectomy: a Prospective Intervention Study
Study Type
Interventional
2. Study Status
Record Verification Date
February 2022
Overall Recruitment Status
Recruiting
Study Start Date
September 4, 2020 (Actual)
Primary Completion Date
August 31, 2022 (Anticipated)
Study Completion Date
November 30, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University Hospital, Linkoeping
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Approximately 4,000 procedures with hysterectomy for benign indication are performed annually in Sweden. There are large differences in preoperative information, planning of surgery and surgical technique. A structured approach including the use of mobile phone technology can possibly improve patient information and patient involvement. Our purpose is to to evaluate whether systematic preoperative preparation improves the outcome of elective hysterectomy on benign indication.
Detailed Description
Background Approximately 4,000 procedures with hysterectomy for benign indication are performed annually in Sweden. There are large differences between clinics in Sweden in the proportion of hysterectomies conducted using minimally invasive surgery. There is no uniformity in the planning of surgery. Patient-reported outcome measures, such as satisfaction and postoperatively unexpected symptoms, are important in assessing the outcome of surgery. Patient-reported measurements are, besides other factors, dependent on preoperative information. Mobile phone technology can possibly improve patient information and patient involvement.
Purpose
To evaluate whether a systematic preoperative preparation improves the outcome of elective hysterectomy on benign indication. The work consists of three parts with the following purposes:
Sub-study 1: To evaluate the effect of a preoperative algorithm for determining the most appropriate method of hysterectomy on the proportion undergoing surgery as a minimally invasive procedure and on the frequency of complications.
Sub-study 2: To compare patient-reported outcome measures, including unexpected symptoms, recovery, and satisfaction, in women who receive systematic preoperative information from specially trained staff and a mobile application with targeted education on the procedure, with women who receive information according to normal routines.
Sub-study 3: To investigate how women experience digitized information via a mobile application in connection with surgery.
Participating centers Departments of obstetrics and gynecology at the hospitals in Norrköping, Jönköping, Eksjö, Värnamo, Västervik, Kalmar and Växjö.
Schedule The study starts in September 2020. Recruitment of patients is planned to take two years.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Benign Hysterectomy, Postoperative Recovery, Preoperative Planning
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Non-Randomized
Enrollment
320 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intensified preoperative information
Arm Type
Experimental
Arm Description
The patient participating in the intervention group is evaluated preoperatively based on an algorithm. This information is designed according to a checklist which includes how the procedure is performed, rules of conduct in connection with and after the procedure and what the patient can expect after surgery.
Arm Title
Control group
Arm Type
No Intervention
Arm Description
The patient who participates in the control group receives information about participation in the study as a control, ie without information about the intervention. The patient will then be planned for the procedure according to current, local routines.
Intervention Type
Other
Intervention Name(s)
Intiensified structured perioperative information
Intervention Description
The doctor takes a medical history and examines the patient according to regular routines, but uses the algorithm as support in deciding on the surgical method. After the doctor's visit, the patient must see a research nurse to receive the intensified preoperative information about hysterectomy. This information is designed according to a checklist. The patient can also download a mobile application. The study-specific mobile application (app) contains information about hysterectomy. The information is structured in three parts - Before the Operation, At the Hospital and After the Operation. A timeline describes the activities and events that occur before, around and after the operation. Within each section there are several information links, with eg checklists.
Primary Outcome Measure Information:
Title
Unexpected postoperative symtoms
Description
Proportion of patients with unexpected symptoms.
Time Frame
Up to one year postoperatively
Title
Proportion minimally invasive hysterectomy
Description
Proportion of women undergoing hysterectomy as a minimally invasive procedure
Time Frame
Retrospecive data 5 years before study start until completion of prospective study
Secondary Outcome Measure Information:
Title
Complication
Description
Numbers of and types of patient reported complications
Time Frame
Up to one year postoperatively
Title
Lenght of stay
Description
Hospital length of stay in connection with surgery
Time Frame
Day of surgery until discharge from hospital pre- and during the intervention
Title
Sick leave
Description
return to work measured as actual sick leave length
Time Frame
Day of discharge from hospital after surgery until return to normal work, maximal one year
Title
Recovery
Description
time to normal daily activity (ADL)
Time Frame
Day of surgery until normal ADL, maximal one year
Title
Health related quality of life
Description
Measured with EuroQol EQ-5D-3L health index comprising of two parts. Part A Scale -0.5941 to 1. A higher number indicates better quality of life. Part B. EuroQol visual analoque scale EQ-VAS. Scale 0-100. A higher number indicates better quality of life
Time Frame
Preoperatively up to one year postoperatively
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
Patients undergoing hysterectomy
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Women 18 - 55 years old.
Women undergoing hysterectomy for benign indication.
Women with ASA 1 - 3.
Women who understand and can express themselves in Swedish.
Women who, by signing "Informed Consent", agree to participate in the study after written and oral information.
Women who participate and respond to the surveys in the GynOp register.
Women who have access to an I-phone, smartphone, computer or tablet and who can use the study-specific mobile application. (Does not apply to sub-study 1).
Exclusion criteria
Women where both ovaries are removed during the operation.
Women undergoing hysterectomy for prolapse indication.
Women undergoing hysterectomy for cancer prophylactic indication.
Women undergoing hysterectomy for gender reassignment purposes.
Women with intellectual disabilities to such an extent that they can not fill in the relevant questionnaires etc. or if they do not understand the meaning of participating in the study or where there may be ethical doubts about the patient's participation in the study.
Women who have a mental illness of such severity that the doctor in charge considers it inappropriate for the patient to be included in the study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Preben Kjölhede, MD PhD
Phone
+46101030000
Email
preben.kjolhede@liu.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Preben Kjölhede, MD PhD
Organizational Affiliation
University Hospital, Linköing
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Lollo Makdessi, MD
Organizational Affiliation
Vrinnevi Hospital, Norrköping
Official's Role
Study Chair
Facility Information:
Facility Name
University Hospital
City
Linköping
ZIP/Postal Code
58185
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Preben Kjölhede, Professor
Phone
+46101030000
Email
preben.kjolhede@liu.se
Facility Name
Vrinnevisjukhuset
City
Norrköping
ZIP/Postal Code
58185
Country
Sweden
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lollo Makdessi Björklund, MD
Phone
+46101030000
Email
lollo.makdessi.bjorklund@regionostergotland.se
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
33574624
Citation
Bjorkstrom LM, Wodlin NB, Nilsson L, Kjolhede P. The Impact of Preoperative Assessment and Planning on the Outcome of Benign Hysterectomy - a Systematic Review. Geburtshilfe Frauenheilkd. 2021 Feb;81(2):200-213. doi: 10.1055/a-1263-0811. Epub 2021 Feb 8.
Results Reference
background
Learn more about this trial
Hysterectomy - A Regional Intervention Study
We'll reach out to this number within 24 hrs